ADPT Adaptive Biotechnologies Corporation - Common Stock
$25,60
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 4, 2026
52W-Spanne
$12–$26
96% of range
Analystenbewertung
BUY
14 analysts
Kursziel
$25
P/E (TTM)
-65.6
ROE
-28.2%
Nettogewinnmarge
-21.5%
Über Adaptive Biotechnologies Corporation - Common Stock Unternehmensübersicht von Wikipedia
ADPT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$25.60
Marktkapitalisierung
$3.94B
P/E (TTM)
-65.6
EPS (TTM)
$-0.39
Umsatz (TTM)
$277M
Dividendenrendite
—
ROE
-28.2%
Verschuldungsgrad
0.6
52W-Spanne
$12 – $26
ADPT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$277M
2017-12-31
→
2025-12-31
EPS
$-0.39
2020-12-31
→
2025-12-31
Freier Cashflow
$-49M
2019-12-31
→
2025-12-31
Margen
-21.5%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ADPT
Peer-Median
P/E (TTM)
-65.6
91.9
P/S (TTM) (K/V (TTM))
14.2
4.4
P/B (K/B)
18.0
3.0
EV / EBITDA
-70.0
—
Price / FCF (Kurs / FCF)
-80.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ADPT
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-20.6%
—
Net Profit Margin (Nettogewinnmarge)
-21.5%
-16.7%
ROA
-11.3%
-7.4%
ROE
-28.2%
-15.5%
ROIC
-16.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ADPT
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.6
0.1
Current Ratio (Liquiditätsgrad)
3.3
3.2
Quick Ratio
1.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ADPT
Peer-Median
Revenue YoY (Umsatz YoY)
54.8%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
14.3%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
23.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ADPT
Peer-Median
ADPT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 5 35,7%
- Kauf 7 50,0%
- Halten 2 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
7 Analysten · 2026-08-19
Median
$25.00
Jetzt
$25.60
Tief
$21.00
Hoch
$28.00
Median-Ziel
$25.00
-2,3%
Mittelwert-Ziel
$25.07
-2,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.09%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.10 | $-0.14 | 0.04% |
| 31. März 2026 | $-0.12 | $-0.16 | 0.04% |
| 31. Dezember 2025 | $-0.09 | $-0.18 | 0.09% |
| 30. September 2025 | $0.06 | $-0.15 | 0.21% |
| 30. Juni 2025 | $-0.17 | $-0.24 | 0.07% |
| 31. März 2025 | $-0.20 | $-0.30 | 0.10% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | — |
| BIO | — | — | — | — | — | — |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ALMR | — | — | — | — | — | — |
| MRVI | — | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| BLFS | — | -241.8 | 28.9% | — | — | — |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $277M | $179M | $170M | $185M | $154M | $98M | $85M | $56M | |
| Cost of Revenue | $71M | $72M | $76M | $58M | $49M | $23M | $22M | $20M | |
| R&D Expense | $94M | $103M | $122M | $142M | $142M | $116M | $71M | $39M | |
| SG&A Expense | $73M | $73M | $84M | $89M | $75M | $50M | $30M | $20M | |
| Operating Expenses | $334M | $342M | $397M | $385M | $363M | $251M | $163M | $105M | |
| Operating Income | $-57M | $-163M | $-227M | $-200M | $-209M | $-153M | $-78M | $-50M | |
| Interest Expense | $12M | $12M | $14M | $4M | · | · | · | · | |
| Pretax Income | $-59M | $-160M | $-225M | $-200M | $-207M | $-146M | $-69M | · | |
| Income Tax | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Income | $-59M | $-159M | $-225M | $-200M | $-207M | $-146M | $-69M | $-46M | |
| EPS (Basic) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · | |
| EPS (Diluted) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · | |
| Shares (Basic) | 151,721,939 | 147,101,648 | 144,383,294 | 142,515,917 | 140,354,915 | 131,216,468 | · | · | |
| Shares (Diluted) | 151,721,939 | 147,101,648 | 144,383,294 | 142,515,917 | 140,354,915 | 131,216,468 | · | · | |
| EBITDA | $-57M | $-163M | $-227M | $-200M | $-209M | $-153M | $-78M | · |
Bilanz 27
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70M | $48M | $65M | $90M | $139M | $123M | $97M | $55M | |
| Receivables | $50M | $42M | $38M | $40M | $17M | $10M | $13M | $5M | |
| Inventory | $10M | $8M | $14M | $14M | $19M | $14M | $9M | $8M | |
| Prepaid Expense | $13M | $11M | $11M | $9M | $13M | $15M | $14M | $3M | |
| Current Assets | $300M | $284M | $410M | $562M | $403M | $727M | $613M | $181M | |
| PP&E (Net) | $34M | $49M | $68M | $83M | $85M | $40M | $60M | $19M | |
| PP&E (Gross) | $130M | $136M | $141M | $138M | $121M | $64M | $78M | $32M | |
| Accum. Depreciation | $96M | $88M | $73M | $54M | $36M | $24M | $18M | $12M | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | |
| Intangibles | $2M | $3M | $5M | $7M | $9M | $10M | $12M | $14M | |
| Other Non-current Assets | $1M | $2M | $4M | $2M | $875.0K | $598.0K | $784.0K | $186.0K | |
| Total Assets | $513M | $539M | $661M | $857M | $923M | $1.12B | $912M | $333M | |
| Accounts Payable | $6M | $7M | $8M | $8M | $3M | $3M | $4M | $2M | |
| Accrued Liabilities | $8M | $8M | $9M | $12M | $9M | $13M | $4M | $3M | |
| Current Liabilities | $90M | $98M | $88M | $110M | $114M | $105M | $78M | $23M | |
| Capital Leases | $70M | $79M | $89M | $99M | $107M | $104M | · | · | |
| Other Non-current Liabilities | $20.0K | $20.0K | · | · | · | · | $93.0K | · | |
| Total Liabilities | $288M | $337M | $353M | $393M | $319M | $373M | $341M | $30M | |
| Long-term Debt | $131M | $133M | · | · | · | · | · | · | |
| Total Debt | $131M | $133M | $131M | · | · | · | · | · | |
| Common Stock | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $1.0K | |
| Paid-in Capital | $1.58B | $1.51B | $1.45B | $1.39B | $1.32B | $1.25B | $936M | $38M | |
| Retained Earnings | $-1.36B | $-1.30B | $-1.14B | $-919M | $-719M | $-512M | $-365M | $-296M | |
| AOCI | $253.0K | $166.0K | $215.0K | $-4M | $-1M | $893.0K | $671.0K | $-107.0K | |
| Stockholders' Equity | $219M | $203M | $308M | $464M | $604M | $743M | $571M | $-258M | |
| Liabilities + Equity | $513M | $539M | $661M | $857M | $923M | $1.12B | $912M | $333M | |
| Shares Outstanding | 153,779,418 | 147,773,744 | 145,082,271 | 143,105,002 | 141,393,865 | 137,646,896 | 125,238,142 | 12,841,536 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $17M | $20M | $21M | · | · | · | · | |
| Stock-based Comp | $51M | $54M | $63M | $55M | $43M | $25M | $13M | $11M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | $2M | · | $2M | · | · | · | · | |
| Operating Cash Flow | $-46M | $-95M | $-156M | $-184M | $-193M | $-150M | $205M | $-32M | |
| CapEx | $3M | $4M | $11M | $16M | $62M | $19M | $11M | $6M | |
| Investing Cash Flow | $38M | $78M | $130M | $3M | $181M | $-117M | $-482M | $736.0K | |
| Stock Issued | · | · | · | · | · | $272M | $321M | · | |
| Net Stock Activity | · | · | · | · | · | $272M | · | · | |
| Financing Cash Flow | $30M | $241.0K | $2M | $132M | $27M | $294M | $320M | $1M | |
| Net Change in Cash | $22M | $-17M | $-24M | $-49M | $16M | $27M | $44M | $-30M | |
| Free Cash Flow | $-49M | $-99M | $-167M | $-200M | $-254M | $-168M | $194M | · | |
| Levered FCF | $-61M | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.2% | · | |
| Net Margin | -21.5% | -89.1% | -132.3% | -108.0% | -134.3% | -148.6% | -80.7% | · | |
| Pretax Margin | -21.5% | -89.2% | -132.3% | -108.1% | -134.3% | · | · | · | |
| EBITDA Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.2% | · | |
| ROA | -11.3% | -26.6% | -29.7% | -22.5% | -20.3% | -14.4% | -11.0% | · | |
| ROE | -28.2% | -62.4% | -58.3% | -37.5% | -30.8% | -23.0% | -11.9% | · | |
| ROIC | -16.3% | · | · | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.9 | 4.7 | 5.1 | 3.5 | 6.9 | 7.8 | · | |
| Quick Ratio | 1.3 | 0.9 | 1.2 | 1.2 | 1.4 | 1.3 | 1.4 | · | |
| Debt / Equity | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| Interest Coverage | -4.8 | -14.0 | -16.5 | -47.2 | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | · | |
| Inventory Turnover | 7.8 | 6.3 | 5.2 | 3.4 | 3.0 | 1.9 | 2.6 | · | |
| Receivables Turnover | 6.0 | 4.5 | 4.4 | 6.4 | 11.2 | 8.7 | 9.7 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 54.8% | 5.1% | -8.1% | 20.1% | 56.9% | · | · | · | |
| Revenue CAGR 3Y | 14.3% | 5.1% | 20.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | 23.0% | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $179M | $170M | $185M | $154M | $98M | $85M | · | |
| Net Income TTM | $-59M | $-159M | $-225M | $-200M | $-207M | $-146M | $-69M | · | |
| Market Cap | $2.50B | $886M | $711M | $1.09B | $3.97B | $8.14B | $3.75B | · | |
| Enterprise Value | $2.56B | $971M | $776M | · | · | · | · | · | |
| P/E | -41.6 | -5.6 | -3.1 | -5.5 | -19.0 | -53.3 | · | · | |
| P/S | 9.0 | 5.0 | 4.2 | 5.9 | 25.7 | 82.7 | 44.0 | · | |
| P/B | 11.4 | 4.4 | 2.3 | 2.4 | 6.6 | 11.0 | 6.6 | · | |
| P / Tangible Book | 25.5 | 11.0 | 3.9 | 3.2 | 8.3 | 13.3 | · | · | |
| P / Cash Flow | -54.3 | -9.3 | -4.5 | -5.9 | -20.6 | -54.4 | 18.2 | · | |
| P / FCF | -51.0 | -9.0 | -4.3 | -5.5 | -15.6 | -48.3 | 19.3 | · | |
| EV / EBITDA | -44.8 | -6.0 | -3.4 | · | · | · | · | · | |
| EV / FCF | -52.3 | -9.8 | -4.6 | · | · | · | · | · | |
| EV / Revenue | 9.2 | 5.4 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -2.4% | -18.0% | -31.8% | -18.3% | -5.3% | -1.9% | · | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $71M | $72M | $94M | $59M | $52M | $47M | $46M | $43M | $42M | $46M | $38M | $49M | $38M | $55M | $48M | |
| Cost of Revenue | $20M | $19M | $18M | $18M | $18M | $17M | $18M | $17M | $19M | $18M | $20M | $19M | $18M | $19M | $17M | $15M | |
| R&D Expense | $19M | $24M | $22M | $24M | $24M | $24M | $23M | $24M | $25M | $30M | $29M | $29M | $32M | $33M | $31M | $36M | |
| SG&A Expense | $21M | $21M | $20M | $18M | $18M | $17M | $18M | $17M | $18M | $20M | $21M | $20M | $22M | $21M | $22M | $21M | |
| Operating Expenses | $87M | $90M | $84M | $84M | $84M | $82M | $81M | $79M | $91M | $91M | $117M | $89M | $97M | $95M | $94M | $93M | |
| Operating Income | $-16M | $-19M | $-13M | $10M | $-25M | $-30M | $-34M | $-33M | $-47M | $-49M | $-71M | $-51M | $-48M | $-57M | $-39M | $-45M | |
| Interest Expense | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $653.0K | |
| Net Income | $-40M | $-20M | $-14M | $10M | $-26M | $-30M | $-34M | $-32M | $-46M | $-48M | $-69M | $-50M | $-48M | $-58M | $-40M | $-45M | |
| EPS (Basic) | $-0.25 | $-0.13 | $-0.08 | $0.06 | $-0.17 | $-0.20 | $-0.22 | $-0.22 | $-0.31 | $-0.33 | $-0.48 | $-0.35 | $-0.33 | $-0.40 | $-0.27 | $-0.32 | |
| EPS (Diluted) | $-0.25 | $-0.13 | $-0.08 | $0.06 | $-0.17 | $-0.20 | $-0.22 | $-0.22 | $-0.31 | $-0.33 | $-0.48 | $-0.35 | $-0.33 | $-0.40 | $-0.27 | $-0.32 | |
| Shares (Basic) | 159,855,257 | 155,521,048 | -301,987,680 | 152,432,307 | 152,082,284 | 149,195,028 | -293,616,372 | 147,516,398 | 147,414,095 | 145,787,527 | -288,230,409 | 144,704,868 | 144,397,693 | 143,511,142 | -284,473,578 | 142,928,654 | |
| Shares (Diluted) | 159,855,257 | 155,521,048 | -312,717,480 | 163,162,107 | 152,082,284 | 149,195,028 | -293,616,372 | 147,516,398 | 147,414,095 | 145,787,527 | -288,230,409 | 144,704,868 | 144,397,693 | 143,511,142 | -284,473,578 | 142,928,654 | |
| EBITDA | $-16M | $-19M | · | $10M | $-25M | $-30M | · | $-33M | $-47M | $-49M | · | $-51M | $-48M | $-57M | · | $-45M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $170M | $78M | $70M | $55M | $43M | $51M | $48M | $38M | $60M | $71M | · | $89M | $109M | $95M | · | $218M | |
| Receivables | $50M | $48M | $50M | $45M | $44M | $44M | $42M | $41M | $36M | $42M | · | $31M | $32M | $31M | · | $27M | |
| Inventory | $10M | $11M | $10M | $10M | $8M | $9M | $8M | $12M | $13M | $13M | · | $19M | $19M | $20M | · | $17M | |
| Prepaid Expense | $16M | $14M | $13M | $14M | $11M | $11M | $11M | $12M | $11M | $10M | · | $13M | $9M | $10M | · | $12M | |
| Current Assets | $421M | $292M | $300M | $281M | $262M | $256M | $284M | $308M | $352M | $374M | · | $435M | $477M | $501M | · | $564M | |
| PP&E (Net) | $29M | $31M | $34M | $37M | $41M | $44M | $49M | $51M | $55M | $65M | · | $77M | $79M | $81M | · | $87M | |
| PP&E (Gross) | · | · | $130M | · | · | · | $136M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $96M | · | · | · | $88M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | · | $119M | $119M | $119M | · | $119M | |
| Intangibles | $884.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | · | $6M | $6M | $6M | · | $7M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | · | $3M | $3M | $2M | · | $2M | |
| Total Assets | $641M | $506M | $513M | $491M | $497M | $511M | $539M | $559M | $585M | $620M | · | $718M | $765M | $791M | · | $884M | |
| Accounts Payable | $5M | $10M | $6M | $10M | $7M | $6M | $7M | $7M | $10M | $12M | · | $4M | $9M | $6M | · | $4M | |
| Accrued Liabilities | $11M | $7M | $8M | $7M | $7M | $8M | $8M | $6M | $7M | $8M | · | $10M | $8M | $8M | · | $11M | |
| Current Liabilities | $88M | $87M | $90M | $83M | $92M | $88M | $98M | $88M | $88M | $83M | · | $93M | $95M | $90M | · | $104M | |
| Capital Leases | $67M | $69M | $70M | $72M | $74M | $76M | $79M | $82M | $84M | $87M | · | $92M | $94M | $96M | · | $101M | |
| Other Non-current Liabilities | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $490M | $282M | $288M | $286M | $317M | $321M | $337M | $335M | $343M | $346M | · | $356M | $369M | $368M | · | $396M | |
| Long-term Debt | $0 | $131M | $131M | $132M | $134M | $134M | $133M | · | · | · | · | $130M | · | · | · | · | |
| Total Debt | $0 | $131M | · | $132M | $134M | $134M | · | $133M | $132M | $132M | · | $130M | · | · | · | · | |
| Common Stock | $16.0K | $16.0K | $15.0K | $15.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $14.0K | $14.0K | $14.0K | · | $14.0K | |
| Paid-in Capital | $1.57B | $1.60B | $1.58B | $1.55B | $1.54B | $1.52B | $1.51B | $1.49B | $1.48B | $1.47B | · | $1.44B | $1.42B | $1.40B | · | $1.37B | |
| Retained Earnings | $-1.42B | $-1.38B | $-1.36B | $-1.35B | $-1.36B | $-1.33B | $-1.30B | $-1.27B | $-1.24B | $-1.19B | · | $-1.07B | $-1.02B | $-977M | · | $-879M | |
| AOCI | $-212.0K | $-28.0K | $253.0K | $211.0K | $73.0K | $134.0K | $166.0K | $497.0K | $-182.0K | $-106.0K | · | $-250.0K | $-893.0K | $-2M | · | $-6M | |
| Stockholders' Equity | $143M | $216M | $219M | $204M | $180M | $190M | $203M | $224M | $242M | $275M | · | $362M | $396M | $424M | · | $488M | |
| Liabilities + Equity | $641M | $506M | $513M | $491M | $497M | $511M | $539M | $559M | $585M | $620M | · | $718M | $765M | $791M | · | $884M | |
| Shares Outstanding | 159,059,622 | 159,697,221 | 153,779,418 | 152,581,042 | 152,234,772 | 151,916,722 | 147,773,744 | 147,561,586 | 147,462,201 | 147,368,324 | · | 144,772,751 | 144,645,118 | 144,279,969 | · | 142,987,127 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $3M | $6M | $6M | $5M | · | · | |
| Stock-based Comp | $11M | $12M | $13M | $13M | $13M | $12M | $13M | $14M | $13M | $14M | $16M | $15M | $17M | $15M | $14M | $14M | |
| Amort. of Intangibles | $423.0K | $419.0K | $429.0K | $428.0K | $423.0K | $419.0K | $428.0K | $428.0K | $424.0K | $423.0K | $429.0K | $428.0K | $423.0K | $419.0K | $429.0K | $428.0K | |
| Restructuring | · | $643.0K | · | · | · | $0 | $87.0K | $193.0K | $680.0K | $1M | · | · | · | · | · | · | |
| Operating Cash Flow | $-6M | $-10M | $2M | $-7M | $-12M | $-28M | $-12M | $-27M | $-17M | $-38M | $-27M | $-47M | $-24M | $-59M | $-30M | $-42M | |
| CapEx | $1M | $796.0K | $636.0K | $409.0K | $655.0K | $1M | $80.0K | $344.0K | $2M | $2M | $1M | $3M | $4M | $3M | $3M | $5M | |
| Investing Cash Flow | $-43M | $9M | $-8M | $17M | $3M | $26M | $22M | $5M | $6M | $45M | $3M | $26M | $37M | $63M | $-98M | $58M | |
| Financing Cash Flow | $142M | $8M | $22M | $2M | $2M | $5M | $127.0K | $40.0K | $30.0K | $44.0K | $87.0K | $17.0K | $1M | $672.0K | $6.0K | $126M | |
| Net Change in Cash | $92M | $7M | $15M | $12M | $-7M | $3M | $10M | $-22M | $-11M | $6M | $-24M | $-21M | $15M | $4M | $-128M | $141M | |
| Free Cash Flow | · | $-10M | · | · | · | $-30M | · | · | · | $-40M | · | · | · | $-62M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -22.0% | -27.1% | · | 10.9% | -42.5% | -56.5% | · | -70.3% | -109.6% | -116.5% | · | -134.4% | -97.7% | -151.9% | · | -95.0% | |
| Net Margin | -55.6% | -28.3% | · | 10.2% | -43.5% | -56.9% | · | -69.1% | -107.0% | -113.5% | · | -132.7% | -97.7% | -153.3% | · | -94.7% | |
| EBITDA Margin | -22.0% | -27.1% | · | 10.9% | -42.5% | -56.5% | · | -70.3% | -109.6% | -116.5% | · | -134.4% | -97.7% | -151.9% | · | -95.0% | |
| ROA | -7.0% | -3.9% | · | 1.8% | -4.7% | -5.3% | · | -5.0% | -6.9% | -6.7% | · | -6.3% | -6.1% | -7.0% | · | -4.8% | |
| ROE | -24.7% | -9.8% | · | 4.5% | -12.2% | -12.8% | · | -10.9% | -14.5% | -13.6% | · | -11.8% | -10.5% | -11.8% | · | -8.0% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 3.4 | · | 3.4 | 2.8 | 2.9 | · | 3.5 | 4.0 | 4.5 | · | 4.7 | 5.0 | 5.6 | · | 5.4 | |
| Quick Ratio | 2.5 | 1.4 | · | 1.2 | 0.9 | 1.1 | · | 0.9 | 1.1 | 1.4 | · | 1.3 | 1.5 | 1.4 | · | 2.3 | |
| Debt / Equity | 0.0 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | · | · | · | · | |
| Interest Coverage | -5.9 | -6.6 | · | 3.5 | -8.5 | -10.2 | · | -11.1 | -17.6 | -16.3 | · | -14.0 | -13.3 | -16.2 | · | -69.6 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 2.1 | 1.9 | · | 1.7 | 1.7 | 1.5 | · | 1.1 | 1.2 | 1.1 | · | 1.1 | 0.9 | 0.9 | · | 0.8 | |
| Receivables Turnover | 1.5 | 1.5 | · | 2.2 | 1.5 | 1.2 | · | 1.3 | 1.3 | 1.1 | · | 1.3 | 1.8 | 1.4 | · | 2.2 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $295M | $276M | · | $252M | $201M | $184M | · | $169M | $172M | $166M | · | $172M | $178M | $168M | · | $170M | |
| Net Income TTM | $-76M | $-66M | · | $-78M | $-134M | $-156M | · | $-176M | $-192M | $-203M | · | $-201M | $-203M | $-218M | · | $-216M | |
| Market Cap | $3.41B | $2.22B | · | $2.28B | $1.77B | $1.13B | · | $756M | $534M | $473M | · | $789M | $971M | $1.27B | · | $1.02B | |
| Enterprise Value | $3.24B | $2.27B | · | $2.36B | $1.86B | $1.21B | · | $850M | $606M | $533M | · | $830M | · | · | · | · | |
| P/E | -43.8 | -31.5 | · | -28.2 | -12.9 | -7.0 | · | -4.2 | -2.7 | -2.3 | · | -3.9 | -4.7 | -5.8 | · | -4.7 | |
| P/S | 11.6 | 8.0 | · | 9.1 | 8.8 | 6.1 | · | 4.5 | 3.1 | 2.8 | · | 4.6 | 5.5 | 7.6 | · | 6.0 | |
| P/B | 23.9 | 10.2 | · | 11.2 | 9.9 | 5.9 | · | 3.4 | 2.2 | 1.7 | · | 2.2 | 2.5 | 3.0 | · | 2.1 | |
| P / Tangible Book | 148.0 | 23.1 | · | 27.4 | 30.5 | 16.5 | · | 7.5 | 4.5 | 3.1 | · | 3.3 | 3.6 | 4.3 | · | 2.8 | |
| P / Cash Flow | · | -232.4 | · | · | · | -39.6 | · | · | · | -12.3 | · | · | · | -21.5 | · | · | |
| P / FCF | · | -214.5 | · | · | · | -37.9 | · | · | · | -11.9 | · | · | · | -20.5 | · | · | |
| EV / EBITDA | -205.6 | -118.2 | · | 229.3 | -74.5 | -40.9 | · | -26.1 | -12.8 | -10.9 | · | -16.3 | · | · | · | · | |
| EV / FCF | · | -219.6 | · | · | · | -40.7 | · | · | · | -13.4 | · | · | · | · | · | · | |
| EV / Revenue | 11.0 | 8.2 | · | 9.4 | 9.3 | 6.6 | · | 5.0 | 3.5 | 3.2 | · | 4.8 | · | · | · | · | |
| Earnings Yield | -2.3% | -3.2% | · | -3.5% | -7.7% | -14.3% | · | -23.6% | -36.5% | -43.9% | · | -25.7% | -21.2% | -17.3% | · | -21.5% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $277M | $179M | $170M | $185M | $154M |
| Betriebsgewinnmarge % | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% |
| Nettoergebnis | $-59M | $-159M | $-225M | $-200M | $-207M |
| Verwässerte EPS | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.6 | 0.7 | 0.4 | — | — |
| Liquiditätsgrad | 3.3 | 2.9 | 4.7 | 5.1 | 3.5 |
| Quick Ratio | 1.3 | 0.9 | 1.2 | 1.2 | 1.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-49M | $-99M | $-167M | $-200M | $-254M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 316 Einreicher · $2.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 55 (-1 vs. Vorquartal) | 37 (0 vs. Vorquartal) | 108 (+13 vs. Vorquartal) | 79 (-18 vs. Vorquartal) | +7.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $643.365.037 | 29.993.708 | 26,70% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $137.356.941 | 6.403.587 | 5,70% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.465.155 | 5.476.231 | 4,88% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $91.540.985 | 4.267.645 | 3,80% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $75.636.776 | 3.526.190 | 3,14% | Aktien |
| STATE STREET CORP | $74.181.636 | 3.458.388 | 3,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $67.416.242 | 3.142.305 | 2,80% | Aktien |
| UBS Group AG | $61.392.474 | 2.862.120 | 2,55% | Kaufoption |
| Driehaus Capital Management LLC | $54.219.229 | 2.527.703 | 2,25% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $54.153.099 | 2.524.620 | 2,25% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $44.879.492 | 2.092.284 | 1,86% | Aktien |
| ARK Investment Management LLC | $44.837.058 | 2.090.306 | 1,86% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $42.284.385 | 1.971.300 | 1,76% | Kaufoption |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $40.523.000 | 1.889.188 | 1,68% | Aktien |
| TORONTO DOMINION BANK | $38.610.000 | 1.800.000 | 1,60% | Kaufoption |
| Aristotle Atlantic Partners, LLC | $31.871.697 | 1.485.860 | 1,32% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $28.525.411 | 1.329.856 | 1,18% | Aktien |
| Amova Asset Management Americas, Inc. | $28.512.113 | 1.329.856 | 1,18% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $27.000.209 | 1.258.751 | 1,12% | Aktien |
| PERCEPTIVE ADVISORS LLC | $26.111.621 | 1.217.325 | 1,08% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.279.940 | 1.178.552 | 1,05% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $22.993.006 | 1.071.935 | 0,95% | Aktien |
| AMERIPRISE FINANCIAL INC | $21.973.304 | 1.024.394 | 0,91% | Aktien |
| Blue Water Life Science Advisors, LP | $21.667.610 | 1.010.145 | 0,90% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $20.049.508 | 934.709 | 0,83% | Aktien |
| Aberdeen Group plc | $19.712.507 | 918.998 | 0,82% | Aktien |
| Freestone Grove Partners LP | $18.912.208 | 881.688 | 0,78% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $18.228.103 | 849.795 | 0,76% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $16.679.842 | 777.615 | 0,69% | Aktien |
| Granite Investment Partners, LLC | $16.242.305 | 757.217 | 0,67% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $16.124.115 | 751.707 | 0,67% | Aktien |
| Trexquant Investment LP | $15.792.777 | 736.260 | 0,66% | Aktien |
| FMR LLC | $15.183.726 | 707.866 | 0,63% | Aktien |
| BANK OF AMERICA CORP /DE/ | $14.875.790 | 693.510 | 0,62% | Aktien |
| Hillsdale Investment Management Inc. | $14.676.454 | 684.217 | 0,61% | Aktien |
| GOLDMAN SACHS GROUP INC | $13.224.526 | 616.528 | 0,55% | Aktien |
| NEXT CENTURY GROWTH INVESTORS LLC | $13.080.853 | 609.830 | 0,54% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $11.657.753 | 543.485 | 0,48% | Aktien |
| JENNISON ASSOCIATES LLC | $11.594.647 | 540.543 | 0,48% | Aktien |
| ExodusPoint Capital Management, LP | $11.114.232 | 518.146 | 0,46% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $10.830.298 | 504.909 | 0,45% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $10.734.760 | 500.455 | 0,45% | Aktien |
| Parkman Healthcare Partners LLC | $10.445.807 | 486.984 | 0,43% | Aktien |
| Qube Research & Technologies Ltd | $10.290.251 | 479.732 | 0,43% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $10.140.766 | 472.763 | 0,42% | Aktien |
| JANE STREET GROUP, LLC | $10.010.608 | 466.695 | 0,42% | Aktien |
| D. E. Shaw & Co., Inc. | $9.608.034 | 447.927 | 0,40% | Aktien |
| FIRST TRUST ADVISORS LP | $8.962.303 | 417.823 | 0,37% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8.431.888 | 393.095 | 0,35% | Aktien |
| 1492 Capital Management LLC | $8.211.918 | 382.840 | 0,34% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $8.177.770 | 381.248 | 0,34% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.578.735 | 353.321 | 0,31% | Aktien |
| BlackRock, Inc. | $7.573.673 | 353.085 | 0,31% | Aktien |
| AFFINITY WEALTH MANAGEMENT LLC | $7.348.105 | 342.569 | 0,30% | Aktien |
| Lisanti Capital Growth, LLC | $6.974.575 | 325.155 | 0,29% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $6.495.060 | 302.800 | 0,27% | Aktien |
| MARSHALL WACE, LLP | $6.265.095 | 292.079 | 0,26% | Aktien |
| Polar Asset Management Partners Inc. | $5.846.648 | 272.571 | 0,24% | Aktien |
| Allianz Asset Management GmbH | $5.271.693 | 379.805 | 0,22% | Aktien |
| Swiss National Bank | $4.969.965 | 231.700 | 0,21% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $4.700.789 | 219.151 | 0,20% | Aktien |
| Cubist Systematic Strategies, LLC | $4.339.724 | 290.088 | 0,18% | Aktien |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $4.334.983 | 202.097 | 0,18% | Aktien |
| RHUMBLINE ADVISERS | $4.275.746 | 199.336 | 0,18% | Aktien |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3.951.090 | 184.200 | 0,16% | Aktien |
| ARISTEIA CAPITAL, L.L.C. | $3.936.075 | 183.500 | 0,16% | Aktien |
| CITADEL ADVISORS LLC | $3.890.086 | 181.356 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.562.437 | 166.081 | 0,15% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.130.542 | 145.946 | 0,13% | Aktien |
| BLAIR WILLIAM & CO/IL | $3.004.308 | 140.061 | 0,12% | Aktien |
| PRUDENTIAL FINANCIAL INC | $2.987.985 | 139.300 | 0,12% | Aktien |
| Bank of New York Mellon Corp | $2.936.162 | 136.884 | 0,12% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.898.689 | 135.137 | 0,12% | Aktien |
| OSAIC HOLDINGS, INC. | $2.896.766 | 135.053 | 0,12% | Aktien |
| ALGERT GLOBAL LLC | $2.827.753 | 131.830 | 0,12% | Aktien |
| LPL Financial LLC | $2.730.842 | 127.312 | 0,11% | Aktien |
| EP Wealth Advisors, LLC | $2.669.474 | 124.451 | 0,11% | Aktien |
| Ensign Peak Advisors, Inc | $2.590.517 | 120.770 | 0,11% | Aktien |
| Nuveen, LLC | $2.520.868 | 117.523 | 0,10% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.503.687 | 116.722 | 0,10% | Aktien |
| XTX Topco Ltd | $2.424.772 | 113.043 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.384.973 | 171.828 | 0,10% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $2.328.934 | 108.575 | 0,10% | Aktien |
| Freestone Capital Holdings, LLC | $2.225.502 | 103.753 | 0,09% | Aktien |
| Squarepoint Ops LLC | $2.207.141 | 102.897 | 0,09% | Aktien |
| POLEN CAPITAL MANAGEMENT LLC | $2.197.703 | 102.457 | 0,09% | Aktien |
| MORGAN STANLEY | $2.121.202 | 98.890 | 0,09% | Aktien |
| Robertson Stephens Wealth Management, LLC | $2.085.326 | 97.218 | 0,09% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.081.658 | 97.047 | 0,09% | Aktien |
| TWO SIGMA ADVISERS, LP | $2.080.344 | 128.100 | 0,09% | Aktien |
| CITIGROUP INC | $2.043.799 | 95.282 | 0,08% | Aktien |
| Huntleigh Advisors, Inc. | $1.998.523 | 93.171 | 0,08% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.993.973 | 143.658 | 0,08% | Aktien |
| Edge Wealth Management LLC | $1.930.500 | 90.000 | 0,08% | Aktien |
| MetLife Investment Management, LLC | $1.924.944 | 89.741 | 0,08% | Aktien |
| Bellevue Group AG | $1.918.467 | 89.439 | 0,08% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $1.824.579 | 85.062 | 0,08% | Aktien |
| TD Asset Management Inc | $1.762.890 | 82.186 | 0,07% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $1.683.889 | 78.503 | 0,07% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.663.683 | 77.561 | 0,07% | Aktien |
Unternehmensinsider 27 Insider · 16 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Chad M Robins | CEO and Chairman | 6. März 2025 S | 2.959.249 | 0 | 0 | $0 |
| Kyle Piskel | Chief Financial Officer | 16. Mai 2025 S | 269.581 | 0 | 0 | $0 |
| Tycho Peterson | Chief Financial Officer | 5. März 2024 S | 531.553 | 0 | 0 | $0 |
| Chad M Cohen | Chief Financial Officer | 22. Dezember 2021 M | 21.604 | 0 | 0 | $0 |
| Julie Rubinstein | President and COO | 5. März 2025 S | 588.249 | 0 | 0 | $0 |
| Mark R Adams | Chief Operating Officer | 11. April 2023 S | 175.361 | 0 | 0 | $0 |
| Harlan S Robins | Chief Scientific Officer | 21. Juli 2026 M | 812.058 | 0 | 6 | $-21.129.500 |
| Francis Lo | Chief People Officer | 15. Juli 2026 M | 230.713 | 0 | 5 | $-5.241.916 |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | 29. Juni 2026 M | 221.278 | 0 | 2 | $-3.503.510 |
| Stacy L Taylor | SVP and General Counsel | 22. August 2024 S | 139.365 | 0 | 0 | $0 |
| Nitin Sood | Chief Commercial Officer, MRD | 8. August 2023 S | 214.808 | 0 | 0 | $0 |
| Lance Baldo | Chief Medical Officer | 8. März 2022 S | 17.171 | 0 | 0 | $0 |
| Jyoti Palaniappan | SVP, Diagnostics, T-Detect | 19. Juli 2021 M | 9.158 | 0 | 0 | $0 |
| Henning Thorsen | SVP, Commercial Operations | 17. Mai 2021 A | 29.061 | 0 | 0 | $0 |
| Nancy Louise Hill | EVP, Operations & Program Mana | 19. Januar 2021 M | 10.000 | 0 | 0 | $0 |
| Charles Sang | SVP, External Affairs | 11. Dezember 2020 M | 0 | 0 | 0 | $0 |
| Michelle Renee Griffin | Direktor | 25. Juni 2026 M | 15.625 | 0 | 3 | $-2.000.259 |
| Katey Einterz Owen | Direktor | 4. März 2025 A | 72.629 | 0 | 0 | $0 |
| Michael J Pellini | Direktor | 4. März 2025 A | 69.690 | 0 | 0 | $0 |
| Kevin T Conroy | Direktor | 6. März 2023 A | 22.968 | 0 | 0 | $0 |
| Leslie Trigg | Direktor | 6. März 2023 A | 25.907 | 0 | 0 | $0 |
| David E. Goel | Direktor | 15. Februar 2021 A | 1.504 | 0 | 0 | $0 |
| Andris A Zoltners | Direktor | 13. Februar 2020 A | 3.621.016 | 0 | 0 | $0 |
| Susan Bobulsky | — | 10. August 2026 S | 396.989 | 0 | 7 | $-627.390 |
| Robert Hershberg | — | 4. März 2026 A | 62.347 | 0 | 1 | $-367.488 |
| Peter M Neupert | — | 4. März 2026 A | 240.315 | 0 | 0 | $0 |
| Eric Dobmeier | — | 14. Februar 2021 A | 1.504 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 49 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,42% | 2.123.561 NS | 30. April 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,74% | 65.865 NS | 30. April 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 1,06% | 20.675 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,33% | 247.631 NS | 30. April 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,18% | 194.092 NS | 30. Juni 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,16% | 10.411 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,15% | 74.955 NS | 31. Mai 2026 | N-PORT |
| ESSC · Strategy Shares | 0,15% | 2.670 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,12% | 5.692 NS | 31. Mai 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 99.767 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,09% | 59.120 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 38.966 NS | 30. April 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,07% | 9.805 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 23.092 NS | 30. April 2026 | N-PORT |
| RSSL · Global X Funds | 0,06% | 64.737 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 7.032 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 572.294 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,03% | 5.500 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 52.346 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 5.565 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 140 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 9.089 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 42.372 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 28.496 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 75.853 NS | 31. Mai 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 15 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 5. August 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IBB · iShares Trust | — | — | 18. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 23. Juli 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13. Juli 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | — | — | 20. Juli 2026 | Täglich |
| ISCB · iShares Trust | — | — | 5. August 2026 | Täglich |
| ISCG · iShares Trust | — | — | 5. August 2026 | Täglich |
| SMLF · iShares Trust | — | — | 10. August 2026 | Täglich |
| ESML · iShares Trust | — | — | 14. August 2026 | Täglich |
| WSML · iShares Trust | — | — | 5. August 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |